Momelotinib: Mechanism of action, clinical, and translational science

Momelotinib: Mechanism of action, clinical, and translational science

Abstract Myelofibrosis is a chronic myeloproliferative disorder characterized by bone marrow fibrosis, splenomegaly, anemia, and constitutional symptoms, with a median survival of ≈6 years from diagnosis. While currently approved Janus kinase (JAK) inhibitors (ruxolitinib, fedratinib) improve spleno...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgios Vlasakakis (Author), Michael T. McCabe (Author), Yu Liu Ho (Author), Geraldine Ferron‐Brady (Author), Paul Martin (Author), Darren Bentley (Author), Catherine Ellis (Author), Mary Antonysamy (Author), Sandra A. G. Visser (Author)
Format: Book
Published: Wiley, 2024-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items